Cepheid receives CE mark for Xpert NPM1 Mutation
June 2, 2023 – Cepheid announced that it has received the CE mark for Xpert NPM1 Mutation, a molecular in vitro diagnostic test for the quantification of mutant…
Read MoreJune 2, 2023 – Cepheid announced that it has received the CE mark for Xpert NPM1 Mutation, a molecular in vitro diagnostic test for the quantification of mutant…
Read MoreJune 1, 2023 – Teleflex announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1st, 2023, the new agreements allow Premier…